IDH Mutations in AML Patients; A higher Association with Intermediate Risk Cytogenetics

Abstract

IDH mutation is mainly associated with intermediate risk AML and when integrated in this specific subgroup displays a lower survival and can be considered an additional integrated molecular risk marker for AML prognosis.<br />.